We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+11.94%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.73B
AUM Growth
+$6.46M
Cap. Flow
-$42.8M
Cap. Flow %
-2.48%
Top 10 Hldgs %
30.81%
Holding
279
New
77
Increased
40
Reduced
47
Closed
83

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$14.4M
2
ILMN icon
Illumina
ILMN
+$11.2M
3
ICUI icon
ICU Medical
ICUI
+$10.4M
4
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
+$9.5M
5
OM icon
Outset Medical
OM
+$8.23M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$20.5M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$13.9M
3
LUNG icon
Pulmonx
LUNG
+$10.1M
4
NSTG
NanoString Technologies, Inc.
NSTG
+$9.8M
5
EVH icon
Evolent Health
EVH
+$7.06M

Sector Composition

Rank Sector Weight
1 Healthcare 34.81%
2 Industrials 0.32%
3 Materials 0.15%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSTG
51
DELISTED
NanoString Technologies, Inc.
NSTG
$9.75M 0.56%
763,700
-705,847
-48% -$9.8M
AZN icon
52
AstraZeneca
AZN
$246B
$9.6M 0.56%
87,500
+6,086
+7% +$772K
ICUI icon
53
ICU Medical
ICUI
$4.48B
$9.41M 0.54%
+62,500
New +$10.4M
SYK icon
54
PUT
Stryker
SYK
$133B
$9.11M 0.53%
45,000
-250,000
-85% -$52.6M
VRAY
55
CALL
DELISTED
ViewRay, Inc.
VRAY
$9.1M 0.53%
+2,500,000
New +$8.39M
LNTH icon
56
Lantheus
LNTH
$6.57B
$8.7M 0.5%
123,765
-88,473
-42% -$6.7M
XNTK icon
57
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.25B
$7.87M 0.46%
99,200
– –
WBA
58
PUT
DELISTED
Walgreens Boots Alliance
WBA
$7.85M 0.45%
250,000
+100,000
+67% +$3.7M
CTKB icon
59
Cytek Biosciences
CTKB
$621M
$7.76M 0.45%
527,164
+50,000
+10% +$649K
VRTX icon
60
Vertex Pharmaceuticals
VRTX
$133B
$7.75M 0.45%
26,763
+10,000
+60% +$2.88M
TDOC icon
61
PUT
Teladoc Health
TDOC
$1.22B
$7.61M 0.44%
+300,000
New +$10.5M
OLK
62
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$7.52M 0.44%
+619,723
New +$9.5M
BDX icon
63
PUT
Becton Dickinson
BDX
$50B
$7.13M 0.41%
+32,000
New +$7.96M
TGTX icon
64
TG Therapeutics
TGTX
$7.58B
$7.11M 0.41%
1,200,813
+250,000
+26% +$1.64M
HOLX
65
PUT
DELISTED
Hologic
HOLX
$7.1M 0.41%
+110,000
New +$7.62M
TFX icon
66
PUT
Teleflex
TFX
$6.03B
$7.05M 0.41%
35,000
+10,000
+40% +$2.39M
PRVA icon
67
CALL
Privia Health
PRVA
$2.75B
$6.81M 0.39%
200,000
-325,000
-62% -$12M
APYX icon
68
Apyx Medical
APYX
$126M
$6.77M 0.39%
1,508,062
+184,759
+14% +$1.32M
ABBV icon
69
AbbVie
ABBV
$440B
$6.71M 0.39%
+50,000
New +$7.17M
SDGR icon
70
Schrodinger
SDGR
$1.39B
$6.5M 0.38%
260,000
+210,000
+420% +$6.17M
SLGC
71
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$6.42M 0.37%
2,213,200
+90,080
+4% +$379K
PHG icon
72
PUT
Philips
PHG
$26.2B
$6.16M 0.36%
467,149
+233,575
+100% +$3.79M
ATRC icon
73
AtriCure
ATRC
$2.22B
$5.98M 0.35%
152,834
+46,219
+43% +$2.11M
IRTC icon
74
iRhythm Holdings
IRTC
$4.13B
$5.95M 0.34%
47,521
-2,479
-5% -$358K
IRTC icon
75
PUT
iRhythm Holdings
IRTC
$4.13B
$5.89M 0.34%
+47,000
New +$6.79M
1 2
3
4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Pura Vida Investments held 279 positions worth $1.73B, up 0.38% from $1.72B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pura Vida Investments's Q3 2022 filing shows 77 new, 40 increased, 47 reduced and 83 closed positions. Its largest new stake was Illumina: 56,540 shares worth $10.5M. The largest sale was Biogen, an estimated $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.

  • Pura Vida Investments's largest Q3 2022 buy was Illumina: 56,540 shares worth $10.5M.
  • Pura Vida Investments added most to United Therapeutics in Q3 2022, an estimated $14.4M increase.
  • Pura Vida Investments's biggest Q3 2022 reduction was Biogen, cutting an estimated $20.5M.
  • Pura Vida Investments fully exited Alnylam Pharmaceuticals in Q3 2022, selling an estimated $13.9M.
  • Pura Vida Investments's ten largest holdings make up 31% of its $1.73B portfolio in Q3 2022.
  • Pura Vida Investments opened 77 new positions and closed 83 in Q3 2022.
  • Pura Vida Investments's portfolio value rose 0.38% quarter-over-quarter to $1.73B.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.